US EditionPublished • loading... • Updated
Pandemic disruptions to health care worsened cancer survival, study suggests
Disruptions to cancer diagnosis and treatment during early COVID-19 likely led to lower one-year survival rates for US patients, according to a new study.
- A new study shows worse one-year cancer survival for U.S. cancer patients diagnosed during the early COVID-19 pandemic.
- Experts had warned that pandemic disruptions to cancer diagnosis and treatment during the early COVID-19 pandemic would cost lives, as shown by warnings from experts.
- Researchers describe a decade-long shift in cancer research producing new approaches like antibody-drug conjugates , amid World Cancer Day coverage.
- The study validates earlier expert concerns that pandemic disruptions harmed cancer outcomes during the early COVID-19 pandemic.
- Amid World Cancer Day coverage, a study's confirmation drew mainstream reporting, including Associated Press coverage, reflecting research and public attention.
Insights by Ground AI
24 Articles
24 Articles
Coverage Details
Total News Sources24
Leaning Left2Leaning Right1Center21Last UpdatedBias Distribution88% Center
Bias Distribution
- 88% of the sources are Center
88% Center
C 88%
Factuality
To view factuality data please Upgrade to Premium
